Skip to main content

Table 2 Quality of the studies included in the meta-analysis

From: The prevalence of thyroid disorders in COVID-19 patients: a systematic review and meta-analysis

Title

1nd Author (y) [ref]

Yes

No

Unclear

Not applicable

  

na/Nb

%

na/Nb

%

na/Nb

%

nc

Cohort

Ahhn J (2021) [1]

8/11

72.7

1/11

9.1

-

-

2

Lania A (2020) [17]

7/11

63.6

3/11

27.2

-

-

1

Lui DTW (2021) [14]

5/11

45.4

5/11

45.4

-

-

1

Lui DTW (2021) [18]

8/11

72.7

2/11

18.1

-

-

1

Lui DTW (2021) [12]

7/11

63.6

2/11

18.1

-

-

2

Chinmay (2021) [19]

4/11

36.3

5/11

45.4

-

-

2

 

Max

8

72.7

5

45.4

-

-

-

 

Min

4

36.3

2

18.1

-

-

-

 

Median

7

63.6

2.5

22.6

-

-

-

Cross-sectional

Hashemipour S (2022) [20]

5/8

62.5

2/8

25

-

-

1

Dabas (2021) [21]

6/8

75

2/8

25

-

-

-

 

Max

6

75

2

25

-

-

-

 

Min

5

62.5

2

25

-

-

-

 

Median

5.5

68.75

2

25

-

-

-

  1. aThe number of Joanna Briggs Institute checklist sub-items for cohort, cross-sectional evaluated as “Yes,” “No,” and “Unclear”
  2. bTotal number of sub-items applicable to the cohort/cross-sectional
  3. cNumber of sub-items not applicable to the cohort/cross-sectional